Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Price: $3.17 --0%
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS: -2.14K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($1.12), versus ($1.53) reported last year. Revenue for the quarter came in at $329.9 million, versus $562.1 million reported last year.
For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Lakeland Financial (LKFN) Tops Q1 EPS by 2c
- Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
